These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 1347016)

  • 21. Mls-1a-induced peripheral tolerance to host minor histocompatibility antigens in radiation bone marrow chimeras. Modification of T cell repertoire associated with active suppression and permanent presentation of host antigens.
    Miconnet I; Bruley-Rosset M; Halle-Pannenko O
    J Immunol; 1992 Jun; 148(12):3706-13. PubMed ID: 1534822
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro characterization of a murine recipient anti-donor effector cell responsible for the development of chronic graft-versus-host disease.
    Fast LD
    J Immunol; 1991 Sep; 147(6):1731-8. PubMed ID: 1909729
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Repopulation of host lymphohematopoietic systems by donor cells during graft-versus-host reaction in unirradiated adult F1 mice injected with parental lymphocytes.
    Hakim FT; Sharrow SO; Payne S; Shearer GM
    J Immunol; 1991 Apr; 146(7):2108-15. PubMed ID: 1672343
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lethal graft-versus-host disease in mice directed to multiple minor histocompatibility antigens: features of CD8+ and CD4+ T cell responses.
    Korngold R
    Bone Marrow Transplant; 1992 May; 9(5):355-64. PubMed ID: 1352163
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential expression of Fas and Fas ligand in acute and chronic graft-versus-host disease: up-regulation of Fas and Fas ligand requires CD8+ T cell activation and IFN-gamma production.
    Shustov A; Nguyen P; Finkelman F; Elkon KB; Via CS
    J Immunol; 1998 Sep; 161(6):2848-55. PubMed ID: 9743345
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Microheterogeneity in regulatory circuits for T-cell alloresponsiveness.
    Gorczynski RM; Macrae S
    Immunology; 1981 Dec; 44(4):827-46. PubMed ID: 6172375
    [TBL] [Abstract][Full Text] [Related]  

  • 27. IL-12 stimulates the development of acute graft-versus-host disease in mice that normally would develop chronic, autoimmune graft-versus-host disease.
    Via CS; Rus V; Gately MK; Finkelman FD
    J Immunol; 1994 Nov; 153(9):4040-7. PubMed ID: 7930611
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Graft-versus-leukemia and graft-versus-host reactions after donor lymphocyte infusion are initiated by host-type antigen-presenting cells and regulated by regulatory T cells in early and long-term chimeras.
    Xia G; Truitt RL; Johnson BD
    Biol Blood Marrow Transplant; 2006 Apr; 12(4):397-407. PubMed ID: 16545723
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Amelioration of acute graft-versus-host disease and re-establishment of tolerance by short-term treatment with an anti-TCR antibody.
    Maeda T; Eto M; Lin T; Nishimura Y; Kong YY; Nomoto K; Nomoto K
    J Immunol; 1994 Nov; 153(9):4311-20. PubMed ID: 7930630
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Peyer's patch is the essential site in initiating murine acute and lethal graft-versus-host reaction.
    Murai M; Yoneyama H; Ezaki T; Suematsu M; Terashima Y; Harada A; Hamada H; Asakura H; Ishikawa H; Matsushima K
    Nat Immunol; 2003 Feb; 4(2):154-60. PubMed ID: 12524535
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Alloimmunization-activated suppressor cells. I: Abrogation of lethal graft-versus-host reaction directed against non-H-2 antigens.
    Halle-Pannenko O; Pritchard LL; Rappaport H
    Transplantation; 1983 Jul; 36(1):60-8. PubMed ID: 6223422
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Facilitation of parental-strain marrow engraftment by T cells of neonatally-tolerant mice.
    Davenport C; George T; Devora GA; Morris MA; Gordon BE; Kumar V; Bennett M
    Biol Blood Marrow Transplant; 1997 Dec; 3(6):294-303. PubMed ID: 9502296
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anti-receptor anti-MHC cytotoxic T lymphocytes: their role in the resistance to graft vs host reaction.
    Kosmatopoulos K; Algara DS; Orbach-Arbouys S
    J Immunol; 1987 Feb; 138(4):1038-41. PubMed ID: 3492538
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reconstitution of lymphoid tissues under the influence of a subclinical level of graft versus host reaction induced by bone marrow T cells or splenic T cell subsets.
    Hirano M; Arase H; Arase-Fukushi N; Ogasawara K; Iwabuchi K; Miyazaki T; Good RA; Onoé K
    Cell Immunol; 1993 Oct; 151(1):118-32. PubMed ID: 8402923
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Post transplant persistence of host cells augments the intensity of acute graft-versus-host disease and level of donor chimerism, an explanation for graft-versus-host disease and rapid displacement of host cells seen following non-myeloablative stem cell transplantation?
    Hirshfeld E; Weiss L; Kasir J; Zeira M; Slavin S; Shapira MY
    Bone Marrow Transplant; 2006 Sep; 38(5):359-64. PubMed ID: 16862165
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Protection from T helper cell-mediated graft-versus-host disease by the presence of an MHC class I alloantigen is associated with perturbation of MHC class II-restricted responses by class I-derived peptides.
    Leibnitz RR; Lipsky PE; Thiele DL
    J Immunol; 1995 Aug; 155(4):1784-95. PubMed ID: 7636234
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Natural killer activity in (C57BL/6 X DBA/2)F1 hybrids undergoing acute and chronic graft-vs.-host reaction.
    Pattengale PK; Ramstedt U; Gidlund M; Orn A; Axberg I; Wigzell H
    Eur J Immunol; 1983 Nov; 13(11):912-9. PubMed ID: 6641788
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neutralizing IL-12 during induction of murine acute graft-versus-host disease polarizes the cytokine profile toward a Th2-type alloimmune response and confers long term protection from disease.
    Williamson E; Garside P; Bradley JA; More IA; Mowat AM
    J Immunol; 1997 Aug; 159(3):1208-15. PubMed ID: 9233615
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recovery of T cell populations after acute graft-vs-host reaction.
    Hakim FT; Payne S; Shearer GM
    J Immunol; 1994 Jan; 152(1):58-64. PubMed ID: 8254206
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Abrogation of hybrid resistance to bone marrow engraftment by graft-vs-host-induced immune deficiency.
    Hakim FT; Shearer GM
    J Immunol; 1986 Nov; 137(10):3109-16. PubMed ID: 3095424
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.